Latest Fovea Stories
In 2011 — to the consternation of women everywhere — a systematic review of randomized clinical trials showed that routine mammography was of little value to younger women at average or low risk of breast cancer.
Age-related macular degeneration (AMD) is the most frequent cause of blindness in the Western World.
Vision scientists have identified a key player in macular degeneration (MD), raising hope for a treatment for the currently incurable blinding disease.
Adaptive optics technology likely to spur sight-saving interventions, usher in new era of eye disease research, diagnosis and treatment.
ST. LOUIS, March 16, 2011 /PRNewswire/ -- ZeaVision, LLC announced that its Zeaxanthin-based nutraceutical, EyePromise Restore, has been improved with a 25% increase in Omega 3's and the addition of Vitamin D3.
Seahorses are helping scientists gain new understanding about how detailed vision develops â€“ in research which may open a way to restore sight in people with age-related blinding diseases.
ST. LOUIS, July 7 /PRNewswire/ -- ZeaVision's EyePromiseÂ® nutraceutical products are unique science-based formulations designed to support eye health.
GENEVA, May 20 /PRNewswire/ -- Valensa International (Eustis, FL USA) announced the introduction of a new eye health formulation that combines the leading eye health ingredients in a single, easy-to-use product.
PARIS, Oct. 1 /PRNewswire/ -- Fovea Pharmaceuticals announced today that it has entered into a binding agreement with sanofi-aventis to sell 100% of its share to sanofi-aventis.
Three young adults who received gene therapy for a blinding eye condition remained healthy and maintained previous visual gains one year later, according to an August online report in Human Gene Therapy.
- Any of various tropical Old World birds of the family Indicatoridae, some species of which lead people or animals to the nests of wild honeybees. The birds eat the wax and larvae that remain after the nest has been destroyed for its honey.